Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA, Sareban N, Lindner AK, Daller LAJ, Matzhold EM, Hutterer G, Smolle M, Mischinger J, Riedl JM, Seles M, Mannweiler S, Bauernhofer T, Pummer K, Pichler R, Zigeuner R, Schlenke P, Pichler M.
Barth DA, et al. Among authors: matzhold em.
Urol Oncol. 2021 Oct;39(10):736.e9-736.e16. doi: 10.1016/j.urolonc.2021.06.005. Epub 2021 Jul 9.
Urol Oncol. 2021.
PMID: 34247906
Free article.